You are viewing: Japan Brain Monitoring Market analysis
Part of: Brain Monitoring Market (Global)

The Japan Brain Monitoring Market was valued at $165.9 Million in 2023 and projected to reach to $248.1 Million by 2028, representing a compound annual growth rate of 8.4%. Japan's brain monitoring market is poised for robust growth through 2028, driven by the nation's aging population and increasing neurological disorder prevalence.

Japan Brain Monitoring Market (2023-2028) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Japan Brain Monitoring Market Trends and Insights

  • Japan's aging population and rising prevalence of neurological disorders are driving demand for advanced brain monitoring technologies across hospitals, diagnostic centers, and research institutions.
  • The market in Japan benefits from strong healthcare infrastructure, significant investment in medical device innovation, and government support for neurotechnology development. Japan's brain monitoring sector is characterized by increasing adoption of non-invasive monitoring solutions and integration of artificial intelligence in diagnostic platforms.
  • Between 2023 and 2028, Japan is expected to see accelerated growth driven by expanding clinical applications in stroke management, epilepsy monitoring, and sleep disorder diagnosis.
  • Japan's position as a global leader in medical technology manufacturing further strengthens its brain monitoring market, with domestic companies developing cutting-edge solutions for both domestic and international markets..

Key Market Statistics

  • CAGR (2023-2028) 8.4% CAGR
  • Market Size, 2023 ~USD 165.9 Million
  • Forecast, 2028 ~USD 248.1 Million
  • Country Japan

Japan Brain Monitoring Market Overview

Aging Population Driving Demand :

Japan's rapidly aging demographic, with over 29% of the population aged 65+, is significantly increasing the prevalence of neurodegenerative diseases such as Alzheimer's and Parkinson's, creating sustained demand for brain monitoring solutions.

Advanced Healthcare Infrastructure :

Japan's world-class healthcare system and high adoption rate of medical technologies position it as a leader in brain monitoring device deployment across hospitals, clinics, and research institutions.

Strong Government Support :

Japanese government initiatives focused on brain health research and neurological disease prevention are accelerating investment in brain monitoring technologies and clinical applications.

High CAGR Outpacing Global Growth :

Japan's market CAGR of 8.4% significantly exceeds the global average of 6.3%, indicating faster market expansion and greater investment opportunities in the region through 2028.

Japan Brain Monitoring Market Dynamics

  • The market's 8.4% CAGR reflects strong demand from hospitals, diagnostic centers, and research institutions investing in advanced monitoring technologies.
  • Government healthcare policies and substantial R&D funding further support market expansion.
  • Japan's technological expertise and healthcare infrastructure create favorable conditions for innovation in EEG, fMRI, and portable monitoring devices.
  • The market is expected to benefit from rising awareness of early disease detection and preventive neurology, positioning Japan as a key growth market in the Asia-Pacific region..

Related Ecosystem

Diagnostic Imaging

Top Technologies
  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography (CT)
  • CT Scanners
  • Nuclear Imaging
  • Positron Emission Tomography
Top Companies
  • Siemens healthineers
  • PHILIPS HEALTHCARE
  • CANON INC.
  • FUJIFILM Holdings Corporation
  • UNITED IMAGING HEALTHCARE CO., LTD.

    Medical Devices

    Top Technologies
    • Polymerase Chain Reaction (PCR)
    • Magnetic Resonance Imaging (MRI)
    • Disposable Autoinjectors
    • Pulse Oximeters
    • Blood Pressure Monitors
    Top Companies
    • Medtronic plc
    • Abbott Laboratories
    • Stryker Corporation
    • Becton, Dickinson and Company
    • JOHNSON & JOHNSON

      Key Takeaways

      • Japan's brain monitoring market is projected to grow from USD 165.9 million in 2023 to USD 248.1 million by 2028 at an 8.4% CAGR.
      • Japan's aging demographic and high prevalence of neurological conditions are primary drivers of market expansion.
      • Non-invasive monitoring technologies and AI-integrated diagnostic platforms are gaining significant traction in Japan.
      • Japan's advanced healthcare infrastructure and medical device manufacturing expertise position it as a regional innovation leader.

      Brain Monitoring Market Report Scope

      Report Metric Details
      Base Year 2023
      Fastest Growing Segment CEREBRAL OXIMETERS (Type)
      Forecast Period 2023–2028
      Growth Rate CAGR of 6.3% from 2023 to 2028
      Largest Segment NON-INVASIVE PROCEDURES (Procedure)
      Market Size Base Year (Billions) ~USD 3.54 (2023)
      Revenue Forecast (Billions) ~USD 4.8 (2028)
      Segments Covered Product, Type, Usability, Procedure, Modality, Medical Condition, End User

      Japan Brain Monitoring Market Report Segmentation

      7 segment dimensions are covered across the global market.

      By Product

      • Accessories
      • Devices

      By Type

      • Batteries
      • Cables
      • Caps
      • Cerebral Oximeters
      • Ct Scanners
      • Dry Electrodes
      • Eeg Devices
      • Electrodes
      • Emg Devices
      • Icp Monitors
      • Meg Devices
      • Mri Scanners
      • Needle Electrodes
      • Other Accessories
      • Pastes & Gels
      • Pet Scanners
      • Sensors
      • Sleep Monitoring Devices
      • Tcd Devices
      • Wet Electrodes

      By Usability

      • Disposable Accessories
      • Non- Disposable Accessories
      • Non-Disposable Accessories

      By Procedure

      • Invasive Procedures
      • Non-Invasive Procedures

      By Modality

      • Fixed Devices
      • Portable Devices
      • Wearable Devices

      By Medical Condition

      • Dementia
      • Epilepsy
      • Headache Disorders
      • Huntington'S Disease
      • Other Medical Conditions
      • Parkinson'S Disease
      • Sleep Disorders
      • Stroke
      • Traumatic Brain Injury

      By End User

      • Ambulatory Surgery Centers & Clinics
      • Diagnostic Centers
      • Diagnostic Centres
      • Hospitals
      • Neurological Centers
      • Neurological Centres
      • Other End Users

      JAPAN: BRAIN MONITORING MARKET, BY END USER, 2021–2028

      Segment20212022202320242025202620272028CAGR (%)
      AMBULATORY SURGERY CENTERS & CLINICS16.117.920.422.725.528.431.735.211.6
      DIAGNOSTIC CENTRES8.99.811.112.313.715.116.818.510.8
      HOSPITALS87.996.2107.7118.5130.8143.6157.7172.89.9
      NEUROLOGICAL CENTRES29.733.237.942.547.853.559.96712.1
      OTHER END USERS121314.315.616.918.319.821.48.4
      TOTAL154.7170.1191.3211.6234.7259285.931510.5

      Target Audience

      • Medical Device Manufacturers : Manufacturers need Japan-specific market data to develop localized product strategies, understand regulatory requirements, and identify distribution channels for brain monitoring devices in this high-value market.
      • Healthcare Investors & PE Firms : Investors require detailed market sizing, growth projections, and competitive analysis for Japan to evaluate investment opportunities in neurotech companies and healthcare infrastructure expansion.
      • Hospital & Diagnostic Center Operators : Healthcare facility operators need market insights to justify capital expenditure on brain monitoring equipment, understand adoption trends, and benchmark against peer institutions in Japan.
      • Pharmaceutical & Biotech Companies : Pharma companies developing neurological treatments need Japan market data to plan clinical trials, understand patient populations, and identify partnership opportunities with diagnostic providers.
      • Healthcare Consultants & Strategy Firms : Consultants advising healthcare clients require Japan-specific market intelligence to develop market entry strategies, competitive positioning, and long-term growth plans in the brain monitoring sector.

      Key Companies in the Japan Brain Monitoring Market

      CompanyHQOwnershipStrongest segments
      CONMED CORPORATIONUnited StatesPublic CompanyOrthopedic and Sports Medicine (BioBrace, Y-Knot, Hall power tools, arthroscopy ecosystem),General Surgery (AirSeal, Buffalo Filter, endomechanical, electrosurgery),Endoscopic Technologies and Patient Monitoring,
      NATUS MEDICAL INCORPORATEDUnited StatesPrivate CompanyNeurodiagnostic systems (EEG, EMG, ICU monitoring, polysomnography, intra-operative monitoring),Newborn care (hearing screening, jaundice management, brain injury, NICU essentials, NICVIEW),Audiology, otoneurologic, and vestibular systems,
      NIHON KOHDEN CORPORATIONJapanPublic CompanyPatient monitors & clinical information systems,Physiological measuring equipment (EEG/ECG/EMG and related),Defibrillators, AEDs, ventilators, anesthesia and related devices,
      GE HEALTHCAREUnited StatesPublic CompanyImaging,Advanced Visualization Solutions (AVS),Patient Care Solutions (PCS),
      SIEMENS HEALTHINEERS AGGermanyPublic CompanyImaging,Diagnostics,Varian (Oncology),
      COMPUMEDICS LIMITEDAustraliaPublic CompanySleep diagnostics (PSG, HST, Somfit),Neurology diagnostics (EEG, LTM, ambulatory),Brain research & MEG systems,
      MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Surgical, Monitoring, Diabetes),
      EDWARDS LIFESCIENCES CORPORATIONUnited StatesPublic CompanyTranscatheter aortic valve replacement (SAPIEN family),Transcatheter mitral and tricuspid (PASCAL, EVOQUE),Surgical structural heart (INSPIRIS, RESILIA, KONECT, MITRIS),
      CGXCanadaPublic CompanyFilm Entertainment and Content (theatrical, Event Cinema, food service),Media (on-screen, digital signage, advertising solutions),Location-Based Entertainment (Rec Room, Playdium, Junxion, in-theatre gaming),

      CONMED CORPORATION

      CONMED Corporation is a publicly traded U.S. medical device company founded in 1970 with approximately 3,900 employees.

      NATUS MEDICAL INCORPORATED

      Natus Medical Incorporated is a U.S.-based private company founded in 1987 with 1,400 employees specializing in medical devices and monitoring solutions.

      NIHON KOHDEN CORPORATION

      Nihon Kohden Corporation is a Japanese public company founded in 1951 with 6,116 employees, operating in the medical device and healthcare technology industry.

      GE HEALTHCARE

      GE Healthcare is a publicly traded U.S. company established in 2022 with 54,000 employees, providing healthcare technology and solutions.

      SIEMENS HEALTHINEERS AG

      Siemens Healthineers AG is a German public company with roots dating to 1896 and 72,369 employees, operating as a global leader in medical technology and diagnostics.

      COMPUMEDICS LIMITED

      Compumedics Limited is an Australian publicly traded company founded in 1987 with 175 employees, specializing in medical device manufacturing.

      MEDTRONIC

      Medtronic is a publicly traded company founded in Ireland in 1949 with 95,000 employees, serving as a global leader in medical technology and healthcare solutions.

      EDWARDS LIFESCIENCES CORPORATION

      Edwards Lifesciences Corporation is a U.S. public company founded in 1958 with 16,000 employees, specializing in cardiovascular and critical care medical devices.

      CGX

      CGX is a Canadian public company founded in 1912 with 10,000 employees operating across multiple business sectors.

      Reasons to Buy this Report

      • Market Size & Growth Validation : Obtain precise market valuation data for Japan (USD 165.9M in 2023) with verified 8.4% CAGR projections through 2028, enabling accurate financial forecasting and investment planning specific to the Japanese market.
      • Competitive Landscape Intelligence : Understand Japan-specific competitive dynamics, key players, and market share distribution to identify partnership opportunities and competitive positioning strategies in this high-growth regional market.
      • Demographic & Clinical Insights : Access detailed analysis of Japan's aging population trends, neurological disease prevalence, and clinical adoption patterns to tailor product development and market entry strategies effectively.
      • Regulatory & Reimbursement Framework : Gain comprehensive understanding of Japan's healthcare regulations, reimbursement policies, and approval pathways specific to brain monitoring devices to accelerate market entry and commercialization.
      • Strategic Growth Opportunities : Identify high-potential segments, emerging applications, and underserved clinical areas within Japan's brain monitoring market to prioritize resource allocation and maximize ROI in this premium healthcare market.

      Frequently asked questions

      What is the current size of Japan's brain monitoring market?

      Japan's brain monitoring market was valued at USD 165.9 million in 2023 and is expected to reach USD 248.1 million by 2028.

      What is the projected growth rate for Japan's brain monitoring market?

      Japan's brain monitoring market is expected to grow at a compound annual growth rate (CAGR) of 8.4% from 2023 to 2028.

      What are the main drivers of growth in Japan's brain monitoring market?

      Key drivers include Japan's aging population, rising neurological disorder prevalence, advanced healthcare infrastructure, and increasing adoption of AI-integrated diagnostic solutions.

      Which technologies are leading Japan's brain monitoring market expansion?

      Non-invasive monitoring solutions and artificial intelligence-powered diagnostic platforms are the primary technology drivers in Japan's market.

      How does Japan's brain monitoring market compare regionally?

      Japan's 8.4% CAGR outpaces the global average of 6.3%, reflecting strong regional demand and technological advancement in the Asia Pacific region.

      RESEARCH METHODOLOGY

      The study involved four major activities in estimating the current size of the Brain Monitoring market. Exhaustive secondary research was done to collect information on the market and its different sub-segments. The next step was to validate these findings, assumptions, and market sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of the segments and sub-segments.

      Secondary Research

      This research study involved the extensive usage of secondary sources; directories; databases such as Bloomberg Business, Factiva, and Wall Street Journal; white papers and annual reports; company house documents; investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the brain monitoring market. It was also used to obtain important information about the key market players, market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

      Primary Research

      In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information important for this report. Primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing directors, technology and innovation directors, and related executives from various key companies and organizations operating in the brain monitoring market. After the complete market engineering process (which includes calculations for market statistics, market breakdown, market size estimations, market forecasting, and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at.

      Some of the major objectives of primary research are:

      • To validate market segmentation defined through an assessment of the product portfolios of leading players
      • To understand the key industry trends and technologies defining the strategic growth objectives of market players
      • To gather both demand- and supply-side validation of the key factors affecting the market growth
      • To validate assumptions for the market sizing and forecasting model used for this study
      • To understand the market position of leading players in the brain monitoring market and their market share/ranking

      Breakdown Of Primary Participants

      Brain Monitoring Market Size, and Share

      *Others include sales managers, marketing managers, and product managers.

      Note: Tiers are defined based on a company’s total revenue. As of 2019, Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      Both top-down and bottom-up approaches were used to estimate and validate the total size of the Brain Monitoring market. These methods were also used extensively to estimate the size of various subsegments in the market.

      Bottom-up approach

      The bottom-up procedure was adopted to arrive at the overall size of the Brain Monitoring market from the revenue of key players (companies), their shares in the market, and their annual sales of Brain Monitoring products.

      Brain Monitoring Market Size, and Share

      To know about the assumptions considered for the study, Request for Free Sample Report

      Top-down approach

      The overall Brain Monitoring market size was used in the top-down approach to estimate the sizes of other individual markets (mentioned in the market segmentation by product, medical condition, end user, and region) through percentage splits from secondary and primary research.

      For the calculation of each type of specific market segment, the most appropriate immediate-parent market size was used for implementing the top-down approach. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained. Market shares were then estimated for top companies to verify the total market revenue arrived earlier in the bottom-up approach.

      Brain Monitoring Market Size, and Share

      Data Triangulation

      After arriving at the overall market size, from the market size estimation process explained above, the Brain Monitoring market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Brain Monitoring industry.

      Market Definition

      Brain Monitoring is a procedure that monitors the activity of various parameters associated with the functioning of brain, which includes electrical activity, blood flow, magnetic activity, the pressure surrounding the brain, and cerebral oxygen saturation.

      Key Stakeholders

      • World Health Organization (WHO)
      • National Center for Biotechnology Information (NCBI)
      • World Federation of Neurology (WFN)
      • Centers for Disease Control and Prevention (CDC)
      • Epilepsy Foundation
      • American Brain Foundation (ABF)
      • Brain Injury Association of America (BIAA)
      • Neurology Asia Journal
      • Alzheimer's Association
      • American Neurological Association (ANA)
      • European Journal of Neurology

      Report Objectives

      • To define, describe, and forecast the brain monitoring market based on the product, procedure, modality, medical condition, end user, and region.
      • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges).
      • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall brain monitoring market.
      • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders.
      • To profile the key players in the market and comprehensively analyze their market shares and core competencies.
      • To forecast the size of the market segments with respect to four main regions, namely, North America, Asia Pacific, Europe, Latin America, and Middle East & Africa.
      • To track and analyze competitive developments such as new product launches, agreements, collaborations, and expansions.

      Available Customizations:

      MarketsandMarkets offers the following customizations for this market report:

      Company Information

      • Profiling of additional market players (up to 3)
      • Additional country-level analysis of sub-segments such as media, reagents, flow cytometers, and centrifuges.

      Get the Full Brain Monitoring Market Report

      Full forecast, segment splits, and company analysis for all Brain Monitoring Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status